News
According to Business Insider, the pair made a $70 million licensing deal.
Also: Mantra Health appoints medical director; Deep 6 AI creates VP of life sciences role.
Providers will be able to have in-app live video conversations with chronic pain and movement disorder patients, as well as prescribe new settings for their neuromodulation therapies from afar.
Study finds nasal spray delivery offers "many benefits" over traditional approaches to vaccine administration.
Contributed: How femtech is breaking the taboo around women’s health and closing the gender health …
Lina Chan, CEO and founder of Parla reviews femtech's roles in tackling taboo subjects in women's health and outlines the importance of involving women affected in the design process.
The system delivers its results to a companion app in about 20 minutes, according to the agency.
The newsletter will be made up of curated articles to bring readers the most important and interesting news of the week.
Investment firm Kuwait Life Sciences Company's Dr. Mussaad M. Al-Razouki gives a breakdown of recently filed or finalized digital health SPACs, as well as a list of unicorns ripe for a potential merger.
Attorneys from Epstein Becker Green talk the liabilities and ethics of the new plan.
Deprexis, an app used to help mental health, is the 11th app to be approved for medical prescription and reimbursement in Germany so far via DiGA, and MobiHealthNews learns more about the process from Julia Hagen, Health Innovation Hub.